- Silverstein AM.Cellular versus humoral immunity: determinants and consequences of an epic nineteenth century battle. In: Silverstein AM, editors. A History of Immunology. 1st ed. New York: Academic Press Inc.; 1989. pp 38–58.
- Luke TC, Kilbane EM, Jackson JL, Hoffman SL.Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med2006;145: 599–609.
- Hung IF, To KK, Lee CK et al.Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis2011;52: 447–456.
- Köhler G, Milstein C.Continuous cultures of fused cells secreting antibody of predefined specificity. Nature1975;256: 495–497.
- Houdebine LM.Transgenic animal bioreactors. Transgenic Res2000;9: 305–320.
- Lillico SG, Sherman A, McGrew MJ et al.Oviduct-specific expression of two therapeutic proteins in transgenic hens. Proc Natl Acad Sci USA2007;104: 1771–1776.
- Hamers-Casterman C, Atarhouch T, Muyldermans S et al.Naturally occurring antibodies devoid of light chains. Nature1993;363: 446–448.
- van der Linder RH, Frenken LG, de Geus B et al.Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta1999;1431: 37–46.
- Kaplan MH.Immunologic relationship of group A streptococcal strains and human heart tissue. Possible significance for the pathogenesis of rheumatic fever. Am Heart J1963;65: 426–427.
- Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ et al.Guillain–Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977. Amer J Epidemiol1979;110: 105–123.
- Stowe J, Andrews N, Wise L, Miller E.Investigation of the temporal association of Guillain–Barré Syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol2009;169: 382–388.
- Halstead SB.Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res2003;60: 421–467.
- Dejnirattisai W, Jumnainsong A, Onsirisakul N et al.Cross-reacting antibodies enhance dengue virus infection in humans. Science2010;328: 745–748.
- Balsitis SJ, Williams KL, Lachica R et al.Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog2010;6: e1000790.
- Davis D, Chaudhri B, Stephens DM, Carne CA, Willers C, Lachmann PJ.The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens. J Gen Virol1990;71: 1975–1983.
- Taussig MJ, Lachmann PJ.Studies on antigenic competition. II. Abolition of antigenic competition by antibody against or tolerance to the dominant antigen: a model for antigenic competition. Immunol1972;22: 185–197.
- Throsby M, van den Brink E, Jongeneelen M et al.Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE2008;3: e3942.
- Sui J, Hwang WC, Perez S et al.Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol2009;16: 265–273.
- Friesen RH, Koudstaal W, Koldijk MH et al.New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets. PLoS ONE2010;5: e9106.
- Suntharalingam G, Perry MR, Ward S et al.Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med2006;355: 1018–1028.
- Bargou R, Leo E, Zugmaier G et al.Tumor regression in cancer patients by very low doses of a T cell-engaging antibody. Science2008;321: 974–977.
- Sharkey RM, Rossi EA, McBride WJ, Chang CH, Goldenberg DM.Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy. Semin Nucl Med2010;40: 190–203.
- Renegar K, Small PA Jr, Boykins LG, Wright PF.Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol2004;173: 1978–1986.
Open access
554
Views
12
CrossRef citations to date
0
Altmetric
Reviews
The use of antibodies in the prophylaxis and treatment of infections
Peter J LachmannDepartment of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UKCorrespondence[email protected]
Pages 1-5
|
Received 21 Nov 2011, Accepted 20 Mar 2012, Published online: 25 Jan 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.